Glaucoma Surgery Devices Market Size, Share and Growth Outlook, 2026

Glaucoma Surgery Devices Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Glaucoma Surgery Devices Market size is forecast to increase from $1.95 Billion in 2026 to $2.84 Billion in 2034 at a CAGR of 4.8% between 2026 and 2034.

The Glaucoma Surgery Devices market report provides detailed analysis and outlook of Glaucoma Surgery Devices segments including By Product Type (Glaucoma Drainage Devices, Minimally Invasive Surgery Devices, Traditional Surgery Devices & Consumables, Laser Systems, Diamond Knives), By Surgery Type (Minimally Invasive Glaucoma Surgery, Conventional Glaucoma Surgery, Laser Surgery), By Target (Trabecular Meshwork, Suprachoroidal Space, Other Targets), By End User (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Glaucoma Surgery Devices Industry Overview

Innovation in Minimally Invasive Technologies Transforming Glaucoma Management

The glaucoma surgery devices industry is undergoing rapid advancement as healthcare providers increasingly adopt minimally invasive and sustained-treatment approaches to manage elevated intraocular pressure and prevent progressive vision loss. Growing prevalence of glaucoma, rising demand for safer surgical interventions, and increasing emphasis on reducing long-term medication dependence are driving innovation across the sector. Manufacturers are developing novel implants, micro-invasive glaucoma surgery platforms, laser-based procedures, and long-duration drug delivery systems that offer improved patient outcomes while minimizing procedural complexity. The industry is witnessing a significant shift toward technologies that combine efficacy, safety, and convenience to address the long-term management challenges associated with glaucoma.

Novel Implant Technologies Expanding Surgical Treatment Options

Device developers are introducing innovative surgical implants designed to lower intraocular pressure through alternative anatomical pathways. French medical technology company Ciliatech expanded its international presence through the establishment of its first United States subsidiary in New York, creating a strategic center for regulatory activities and future clinical development programs. The expansion follows European regulatory approval of the Intercil® Uveal Spacer under the European Union Medical Device Regulation framework. The device represents a new category within the Cilioscleral Interpositioning Device segment and is specifically engineered to reduce intraocular pressure without entering the anterior chamber of the eye. Clinical evidence from the SAFARI 3 study demonstrated that 70% of treated patients achieved complete freedom from glaucoma medications at the 36-month follow-up period following supraciliary implantation. These findings highlight the growing potential of innovative implant-based approaches to provide durable pressure control while reducing reliance on chronic pharmacological therapy.

Sustained Drug Delivery and Laser-Based Procedures Driving Market Growth

The glaucoma surgery devices market is also benefiting from advances in long-acting therapeutic implants and office-based surgical technologies. Glaukos reported strong commercial momentum driven by physician adoption of iDose TR, a travoprost intracameral implant designed to provide sustained intraocular pressure control for up to three years. The company attributed significant revenue growth to expanding utilization of this long-duration drug delivery platform, supported by broad Medicare reimbursement coverage and increasing physician confidence in sustained-release treatment strategies. Simultaneously, EyeX Solutions introduced the PicoLumen system, a new category of minimally invasive glaucoma surgery that utilizes a low-energy green-wavelength picolaser to perform dynamic photodisruptive trabeculostomy. The technology enables rapid in-office procedures completed in less than half a second while the patient remains in an upright position. These developments illustrate the industry's movement toward less invasive interventions, durable therapeutic solutions, and enhanced patient convenience in glaucoma management.

Glaucoma Surgery Devices Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Glaucoma Surgery Devices market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Alcon (Novartis), Glaukos Corporation, Johnson & Johnson Vision, Boston Scientific Corporation, Ivantis, Inc. (Dexcom/Alcon), New World Medical, Inc., Bausch + Lomb, Nova Eye Medical Limited, Santen Pharmaceutical Co., Ltd., Sight Sciences, Inc.. The Glaucoma Surgery Devices market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Glaucoma Surgery Devices industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Glaucoma Surgery Devices Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Glaucoma Surgery Devices companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Glaucoma Surgery Devices markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Glaucoma Surgery Devices Market Competitive Benchmarking and Company Analysis

Leading companies in Glaucoma Surgery Devices industry include- Alcon (Novartis), Glaukos Corporation, Johnson & Johnson Vision, Boston Scientific Corporation, Ivantis, Inc. (Dexcom/Alcon), New World Medical, Inc., Bausch + Lomb, Nova Eye Medical Limited, Santen Pharmaceutical Co., Ltd., Sight Sciences, Inc.. The Glaucoma Surgery Devices market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Glaucoma Surgery Devices Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Glaucoma Surgery Devices market remains one of the strongest-performing segments in the country.
The US Glaucoma Surgery Devices Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Glaucoma Surgery Devices market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Glaucoma Surgery Devices industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Glaucoma Surgery Devices markets

Canada's strong Glaucoma Surgery Devices sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Glaucoma Surgery Devices market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Glaucoma Surgery Devices Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Glaucoma Surgery Devices market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Glaucoma Surgery Devices population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Glaucoma Surgery Devices industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Glaucoma Surgery Devices market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Glaucoma Surgery Devices sales through 2034

France Glaucoma Surgery Devices companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Glaucoma Surgery Devices Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Glaucoma Surgery Devices distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Glaucoma Surgery Devices Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Glaucoma Surgery Devices market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Glaucoma Surgery Devices industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Glaucoma Surgery Devices industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Glaucoma Surgery Devices Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Glaucoma Surgery Devices market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Glaucoma Surgery Devices market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Glaucoma Surgery Devices Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Glaucoma Surgery Devices Market Segmentation

By Product Type
Glaucoma Drainage Devices
Minimally Invasive Surgery Devices
Traditional Surgery Devices & Consumables
Laser Systems
Diamond Knives
By Surgery Type
Minimally Invasive Glaucoma Surgery
Conventional Glaucoma Surgery
Laser Surgery
By Target
Trabecular Meshwork
Suprachoroidal Space
Other Targets
By End User
Hospitals
Ophthalmic Clinics
Ambulatory Surgical Centers

Top Companies in Glaucoma Surgery Devices Industry

Alcon (Novartis)
Glaukos Corporation
Johnson & Johnson Vision
Boston Scientific Corporation
Ivantis, Inc. (Dexcom/Alcon)
New World Medical, Inc.
Bausch + Lomb
Nova Eye Medical Limited
Santen Pharmaceutical Co., Ltd.
Sight Sciences, Inc.

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025